Skip to main content
Figure 1 | Trials

Figure 1

From: Comparison of everolimus-eluting and biolimus-eluting coronary stents with everolimus-eluting bioresorbable scaffold: study protocol of the randomized controlled EVERBIO II trial

Figure 1

Study algorithm. BES: biolimus-eluting stent, BVS: biovascular scaffold, EES: everolimus-eluting stent, OCT: optical coherence tomography, PCI: percutaneous coronary intervention. aPrimary endpoint: late lumen loss at 9-month angiography study. bSecondary endpoints: patient oriented (death, myocardial infarction, target vessel revascularization), device oriented (cardiac death, myocardial infarction, target-lesion revascularization), stent thrombosis, binary restenosis at 9-month angiography study.

Back to article page